138 related articles for article (PubMed ID: 8580926)
1. Nonparametric test of stochastic ordering for multiple longitudinal measures.
Rosenberger WF; Lachin JM; Bain RP
J Biopharm Stat; 1995 Nov; 5(3):235-43. PubMed ID: 8580926
[TBL] [Abstract][Full Text] [Related]
2. Group sequential monitoring of distribution-free analyses of repeated measures.
Lachin JM
Stat Med; 1997 Mar; 16(6):653-68. PubMed ID: 9131754
[TBL] [Abstract][Full Text] [Related]
3. Vesnarinone: a new inotropic agent for treating congestive heart failure.
Cavusoglu E; Frishman WH; Klapholz M
J Card Fail; 1995 Jun; 1(3):249-57. PubMed ID: 9420657
[TBL] [Abstract][Full Text] [Related]
4. Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group.
Feldman AM; Bristow MR; Parmley WW; Carson PE; Pepine CJ; Gilbert EM; Strobeck JE; Hendrix GH; Powers ER; Bain RP
N Engl J Med; 1993 Jul; 329(3):149-55. PubMed ID: 8515787
[TBL] [Abstract][Full Text] [Related]
5. Effect of vesnarinone on cardiac function in patients with severe congestive heart failure.
Scherrer-Crosbie M; Cocca-Spofford D; DiSalvo TG; Semigran MJ; Dec GW; Picard MH
Am Heart J; 1998 Nov; 136(5):769-77. PubMed ID: 9812070
[TBL] [Abstract][Full Text] [Related]
6. A linear model method for rank measures of association from longitudinal studies with fixed conditions (visits) for data collection and more than two groups.
Jung JW; Koch GG
J Biopharm Stat; 1998 May; 8(2):299-316. PubMed ID: 9598424
[TBL] [Abstract][Full Text] [Related]
7. Visualization and dynamics of multidimensional health-related quality-of-life-adjusted overall survival: a new analytic approach.
Andrei AC; Grady KL
Qual Life Res; 2014 Jun; 23(5):1411-9. PubMed ID: 24395525
[TBL] [Abstract][Full Text] [Related]
8. Sequential monitoring of survival data with the Wilcoxon statistic.
Lan KK; Rosenberger WF; Lachin JM
Biometrics; 1995 Sep; 51(3):1175-83. PubMed ID: 7548701
[TBL] [Abstract][Full Text] [Related]
9. Some large-sample distribution-free estimators and tests for multivariate partially incomplete data from two populations.
Lachin JM
Stat Med; 1992 Jun; 11(9):1151-70. PubMed ID: 1509217
[TBL] [Abstract][Full Text] [Related]
10. Performance of selected nonparametric tests for discrete longitudinal data under different patterns of missing data.
Chirwa TF; Bogaerts J; Chirwa ED; Kazembe LN
J Biopharm Stat; 2009; 19(1):190-203. PubMed ID: 19127475
[TBL] [Abstract][Full Text] [Related]
11. [Effect of Chinese-made vesnarinone on experimental heart failure of dog].
Du J; Yang Z
Hua Xi Yi Ke Da Xue Xue Bao; 1992 Jun; 23(2):178-80. PubMed ID: 1452153
[TBL] [Abstract][Full Text] [Related]
12. Worst-rank score analysis with informatively missing observations in clinical trials.
Lachin JM
Control Clin Trials; 1999 Oct; 20(5):408-22. PubMed ID: 10503801
[TBL] [Abstract][Full Text] [Related]
13. Vesnarinone for heart failure.
Swedberg K; Wedel H
N Engl J Med; 1994 Jan; 330(1):64; author reply 65. PubMed ID: 8259151
[No Abstract] [Full Text] [Related]
14. Digoxin in heart failure.
Chadwell M; French L
J Fam Pract; 1997 May; 44(5):442. PubMed ID: 9152256
[No Abstract] [Full Text] [Related]
15. Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review.
Olsson LG; Swedberg K; Clark AL; Witte KK; Cleland JG
Eur Heart J; 2005 Apr; 26(8):778-93. PubMed ID: 15774495
[TBL] [Abstract][Full Text] [Related]
16. Oral amrinone for the treatment of chronic congestive heart failure: results of a multicenter randomized double-blind and placebo-controlled withdrawal study.
DiBianco R; Shabetai R; Silverman BD; Leier CV; Benotti JR
J Am Coll Cardiol; 1984 Nov; 4(5):855-66. PubMed ID: 6386932
[TBL] [Abstract][Full Text] [Related]
17. Rationale and design of the enoximone clinical trials program.
Lowes BD; Shakar SF; Metra M; Feldman AM; Eichhorn E; Freytag JW; Gerber MJ; Liard JF; Hartman C; Gorczynski R; Evans G; Linseman JV; Stewart J; Robertson AD; Roecker EB; Demets DL; Bristow MR
J Card Fail; 2005 Dec; 11(9):659-69. PubMed ID: 16360960
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a new inotropic agent, OPC-8212, in patients with dilated cardiomyopathy and heart failure.
Feldman AM; Becker LC; Llewellyn MP; Baughman KL
Am Heart J; 1988 Sep; 116(3):771-7. PubMed ID: 3046278
[TBL] [Abstract][Full Text] [Related]
19. Applications of the Wei-Lachin multivariate one-sided test for multiple outcomes on possibly different scales.
Lachin JM
PLoS One; 2014; 9(10):e108784. PubMed ID: 25329662
[TBL] [Abstract][Full Text] [Related]
20. Rationale and design of the pilot randomized study of nesiritide versus dobutamine in heart failure (PRESERVD-HF).
Gheorghiade M; Gattis WA; Adams KF; Jaffe AS; O'Connor CM; ;
Am Heart J; 2003 Feb; 145(2 Suppl):S55-7. PubMed ID: 12594453
[No Abstract] [Full Text] [Related]
[Next] [New Search]
